This company is no longer active
The company may no longer be operating, as it may be out of business. Find out why through their latest events.
INDEX Aperçu des actions
Engages in the research and development of pharmaceuticals for immunological diseases.
| Score flocon de neige | |
|---|---|
| Évaluation | 2/6 |
| Croissance future | 0/6 |
| Performances passées | 0/6 |
| Santé financière | 6/6 |
| Dividendes | 0/6 |
InDex Pharmaceuticals Holding AB (publ) Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | SEK 0.55 |
| Plus haut sur 52 semaines | SEK 0.93 |
| Plus bas sur 52 semaines | SEK 0.20 |
| Bêta | -0.21 |
| 1Variation sur 1 mois | 35.15% |
| Variation sur 3 mois | 88.28% |
| Variation sur 1 an | -4.55% |
| 3Variation sur 3 ans | -63.84% |
| Variation sur 5 ans | -93.87% |
| Évolution depuis l'introduction en bourse | -92.20% |
Nouvelles et mises à jour récentes
Market Might Still Lack Some Conviction On InDex Pharmaceuticals Holding AB (publ) (STO:INDEX) Even After 35% Share Price Boost
Jun 13
Further Upside For InDex Pharmaceuticals Holding AB (publ) (STO:INDEX) Shares Could Introduce Price Risks After 26% Bounce
Apr 28Recent updates
Market Might Still Lack Some Conviction On InDex Pharmaceuticals Holding AB (publ) (STO:INDEX) Even After 35% Share Price Boost
Jun 13Further Upside For InDex Pharmaceuticals Holding AB (publ) (STO:INDEX) Shares Could Introduce Price Risks After 26% Bounce
Apr 28We're Keeping An Eye On InDex Pharmaceuticals Holding's (STO:INDEX) Cash Burn Rate
Jul 11We Think InDex Pharmaceuticals Holding (STO:INDEX) Can Afford To Drive Business Growth
Jan 21We Think InDex Pharmaceuticals Holding (STO:INDEX) Can Afford To Drive Business Growth
Aug 31Here's Why We're Watching InDex Pharmaceuticals Holding's (STO:INDEX) Cash Burn Situation
Mar 29InDex Pharmaceuticals Holding's (STO:INDEX) Shareholders Are Down 24% On Their Investment Over The Past Year.
Feb 04
How Much Are InDex Pharmaceuticals Holding AB (publ) (STO:INDEX) Insiders Spending On Buying Shares?
Dec 21Rendement pour les actionnaires
| INDEX | SE Pharmaceuticals | SE Marché | |
|---|---|---|---|
| 7D | 1.1% | -2.4% | 0.05% |
| 1Y | -4.5% | 46.6% | 28.1% |
Rendement vs Industrie: INDEX underperformed the Swedish Pharmaceuticals industry which returned 88.4% over the past year.
Rendement vs marché: INDEX underperformed the Swedish Market which returned 14.1% over the past year.
Volatilité des prix
| INDEX volatility | |
|---|---|
| INDEX Average Weekly Movement | 7.5% |
| Pharmaceuticals Industry Average Movement | 10.7% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in SE Market | 11.1% |
| 10% least volatile stocks in SE Market | 3.3% |
Cours de l'action stable: INDEX's share price has been volatile over the past 3 months.
Volatilité au fil du temps: INDEX's weekly volatility (7%) has been stable over the past year.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 2000 | 4 | Jenny Sundqvist | www.indexpharma.com |
InDex Pharmaceuticals Holding AB (publ) Résumé des fondamentaux
| INDEX statistiques fondamentales | |
|---|---|
| Capitalisation boursière | SEK 286.59m |
| Bénéfices(TTM) | -SEK 56.48m |
| Recettes(TTM) | SEK 108.34m |
2.7x
Ratio P/S-5.1x
Ratio P/ELe site INDEX est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| INDEX compte de résultat (TTM) | |
|---|---|
| Recettes | SEK 108.34m |
| Coût des recettes | SEK 4.03m |
| Marge brute | SEK 104.31m |
| Autres dépenses | SEK 160.79m |
| Les revenus | -SEK 56.48m |
Derniers bénéfices déclarés
Mar 31, 2024
Prochaine date de publication des résultats
Aug 20, 2024
| Résultat par action (EPS) | -0.11 |
| Marge brute | 96.28% |
| Marge bénéficiaire nette | -52.13% |
| Ratio dettes/capitaux propres | 0% |
Quelles ont été les performances à long terme de INDEX?
Voir les performances historiques et les comparaisons